Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 43Myelodysplastic Syndromes 41Leukemia 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Lymphoma, Non-Hodgkin 24Leukemia, Lymphocytic, Chronic, B-Cell 23Hematologic Neoplasms 22Lymphoma 21Hodgkin Disease 20Multiple Myeloma 14Graft vs Host Disease 14Myeloproliferative Disorders 13Primary Myelofibrosis 11Leukemia, Myelomonocytic, Juvenile 11Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myelomonocytic, Chronic 7Lymphoma, Large-Cell, Immunoblastic 6Leukemia, Myeloid, Accelerated Phase 6Congenital Abnormalities 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Leukemia, Myeloid, Chronic-Phase 5Blast Crisis 5Anemia, Refractory, with Excess of Blasts 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4

Interventions

thymoglobulin 1Fluorescent Antibody Technique 1Cyclophosphamide 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Virus Diseases × thymoglobulin × Other hematologic neoplasm × Clear all
NCT03818334 2019-02-01

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Hospital Israelita Albert Einstein

Phase 2/3 Recruiting
50 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Virus Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡